User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Sep 02 2015 06:51 IST RSS 2.0
 
1 to 20 of 2,598    
HC notice to govt over MNCs' patent disclosure 2.9.2015 TOI: India Business
In a development that could have major ramifications on intellectual property cases in pharmaceutical and technology sectors, the Delhi high court issued a notice to the government on Tuesday in a PIL (public interest litigation) filed by IP expert Shamnad Basheer.
Also found in: [+]
Niti Aayog's wrong prescription 27.8.2015 Rediff: Columns
Taking away free healthcare facilities, as recommended by the Aayog, would place a huge burden on the people, especially in rural areas, says Devanik Saha.
Also found in: [+]
Indian medicine, at 1/100th cost, saves Aussie's life 21.8.2015 ET: Pharma
The 61-year-old Australian, suffering from hepatitis C, desperately needed a drug called Sivoldi to reverse the life-threatening condition.
Also found in: [+]
Lee Pharma seeks hearing on nod for diabetes drug 19.8.2015 TOI: India Business
Hyderabad-based Lee Pharma will seek a " hearing" from the Patent Controller to put forth its case for the compulsory licence to manufacture saxagliptin, a diabetes drug.
Also found in: [+]
India rejects Lee Pharma’s compulsory licence plea 18.8.2015 ET: Pharma
India has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca’s key antidiabetes compound Saxagliptin.
Also found in: [+]
Biocon bets big on its biosimilars offering 15.8.2015 TOI: India Business
Biocon’s biosimilars business is growing strongly, and with many patents for biopharma drugs starting to expire in the developed markets from 2016, biosimilars is expected to add significantly to the company’s topline.
Also found in: [+]
‘Bridge research, industry gap’ 7.8.2015 TOI: Cities
Nanotechnology is all around us – ranging from scratch-proof glass on mobile phones to making solar panels more energy efficient and delivering drugs at molecular ...
Also found in: [+]
Drugmakers up; CLSA says transition to complex drugs to drive re-rating 6.8.2015 Sify Finance
** Indian drugmakers' transition to making complex generics from simple should drive significant re-rating - CLSA
Also found in: [+]
High Court rejects AstraZeneca’s diabetes drug plea 30.7.2015 ET: Pharma
The Delhi High Court has dismissed AstraZeneca’s plea to block Hyderabadbased Lee Pharma from making copies of its anti-diabetes drug Onglyza
Also found in: [+]
Glenmark Pharmaceuticals' Finacea generic infringes Bayer patent - court 28.7.2015 Sify Finance
NEW YORK (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court
Also found in: [+]
India rejects Swiss drug maker Roche Patent claims on Valcyte again 24.7.2015 ET: Pharma
Indian authorities have for the second time rejected Swiss drug maker Roche’s patent claims on valganciclovir, or Valcyte, used to treat an eye infection affecting AIDS patients.
Also found in: [+]
Govt readies IPR policy, says regime TRIPS compliant 21.7.2015 TOI: India Business
The government will unveil India’s maiden intellectual property rights (IPR) policy, amid fears of diluting the country’s stance on crucial areas such as compulsory licensing and other provisions that allow the registrar to reject frivolous patent proposals.
Also found in: [+]
Sensex up 33 points; Suven Life Sciences jumps on bagging product patents 13.7.2015 Sify Finance
Also found in: [+]
Delhi HC Upholds BMS' Patent for Cancer Drug Dasatinib 7.7.2015 ET: Pharma
The Delhi High Court has upheld the patent of US-based BMS for Dasatinib, dashing the hopes of a local company to sell a generic version of the cancer drug
Also found in: [+]
Delhi High Court upholds BMS’ patent for cancer drug Dasatinib 6.7.2015 ET: Pharma
The Indian Patent Office had in 2013 rejected the company’s demand for a compulsory licence as it did not follow the procedures for obtaining a voluntary licence.
Also found in: [+]
Indian company seeks compulsory nod for MNC’s drug 6.7.2015 TOI: India Business
A little-known Hyderabad-based pharma company has filed an application with the Patent Office to manufacture saxagliptin, a diabetes drug patented and marketed in the country by MNC AstraZeneca.
Also found in: [+]
MPP doubles its generic partners, adds more domestic drug firms 1.7.2015 TOI: Cities
The Medicines Patent Pool (MPP) announced the expansion of its network of generic manufacturers to 14 companies now working on over 50 projects to develop MPP-licensed antiretrovirals ...
Also found in: [+]
Glenmark gets US regulator nod for cholesterol drug 30.6.2015 Sify Finance
India's leading new molecules maker Glenmark Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) for its cholesterol-lowering drug Ezetimibe.
Also found in: [+]
Sensex edges higher, looks set to cross 28,000 mark again 24.6.2015 Sify Finance
Also found in: [+]
Focus on data privacy laws to boost medical outsourcing 23.6.2015 ET: Healthcare
The government should introduce proper regulations for intellectual property and patents besides focusing on implementing data privacy laws, a study said.
Also found in: [+]
1 to 20 of 2,598